COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
Paul N. Newton, Katherine C. Bond, Moji Christianah Adeyeye, Marie Antignac, Ayenew Ashenef, Ghulam Rahim Awab, Zaheer-Ud-Din Babar, Wilbert Bannenberg, Katherine C. Bond, Jason Bower, Joel G. Breman, Aleisha Brock, Céline Caillet, Philip E. Coyne, Nicholas Day, Michael Deats, Kawtar Douidy, Kim Doyle, Catherine Dujardin, Chioma Ejekam, Facundo M. Fernández, Clark C. Freifeld, Marie Gill, Philippe J. Guérin, Georgina Joan Harigwo, Lutz Heide, Peter Horby, Harparkash Kaur, Pierre Claver Kayumba, Kazuko Kimura, Cassandra Kelly, Felix Khuluza, Stephen Kigera, Mirza Lalani, Marie Lamy, Marya Lieberman, Murray Lumpkin, Tim K. Mackey, Bernard Naughton, Paul N. Newton, Philip Nguyen, Piero Olliaro, Sachiko Ozawa, Anushka Patel, Souly Phanouvong, Elizabeth Pisani, Oksana Pyzik, Lembit Rägo, Mohammad Sofiqur Rahman, Eurek Ranjit, Raffaella Ravinetto, David Richmond, Sauman Singh-Phulgenda, Jaap Venema, A. E. Van Vogt, Sir Nicholas White, Veronika J. Wirtz, Muhammad H. Zaman (2020). COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. The Lancet Global Health, 8(6), pp. e754-e755, DOI: 10.1016/s2214-109x(20)30136-4.
